Abstract
In the early 1930’s, the discovery of artificial radioactivity was universally greeted by a burst of enthusiasm as a possible solution to many therapeutic radiological problems. Even more realistically, especially from an economic viewpoint, the availability of the products of the chain reactor in the middle 1940’s seemed to open up much wider vistas in the field of radiation therapy. Now one was offered an assortment of isotopes of practically all the existing elements as a means of combatting malignant disease by means of application of newly existent radioactive elements as well as nuclide containing compounds which could be tailor-made according to the desires of the investigator. However, real progress has been exasperatingly slow. Attempts to find the reason why by questioning of competent investigators in the field on two continents have failed to reveal a definitive answer. With such a large potential armamentarium available there should be suggested a question of lack of ingenuity and interest. In spite of the tremendous amounts of money which have been expended to develop chemotherapeutic agents for control of malignant processes the results have been very disappointing. Therefore, radiation alone and as an adjuvant to surgery still holds tremendous possibilities in the management of cancer until such a time as a major “break-through” in cancer therapy may be effected by other means. The situation is not dissimilar to that which existed fifteen years ago when the reactor products were first made available and there may well be another equal or longer period of time during which such nuclides could be advantageously used in the treatment of cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. M. A. Council on Pharmacy and Chemistry. New and non-official remedies. J. Amer. med. Ass. 159, 1294 (1955).
Andrews, G. A.: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Beierwaltes, W. H., P. C. Johnson and A. J. Solari: Clinical use of radioisotopes. Philadelphia: W. B. Saunders Company 1957.
Chevalier, A., and C. Burg: Personal communication to author.
Dameshek, W. : Physiopathology and course of polycythemia vera as related to therapy. J. Amer. med. Ass. 142, 700–797 (1950).
Dickson, K. J., and E. K. Lang: Treatment of papillomata of the bladder with radioactive colloidal gold Au 198. Amer. J. Roentgenol. 83, 116–122 (1960).
Duffy, B. J.: Can radiation cause thyroid cancer? J. clin. Endocr. 17, 1383–1388 (1957).
Ellis, F., and R. Oliver: Treatment of papilloma of bladder with radioactive colloidal gold Au 198. Brit. med. J. 1955 I, 136–139.
Fellinger, K., u. H. Vetter: Radioaktive Isotope in Klinik und Forschung. Strahlentherapie Sonderbd. 33, 175–182 (1955).
Flocks, R. H., D. A. Culp, H. B. Elkins and T.C. Evans : Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Freedberg, A. S., G.S.Kurland and H.L. Blumgart: The pathologic effects of I 131 on the normal thyroid gland of man. J. clin. Endocr. 12, 1315–1348 (1952).
Goldie, H., and P. F. Hahn: Effects of radioactive iodine on free sarcoma 37 cells in peritoneal fluid of mouse. Proc. Soc. exp. Biol. (N.Y.) 74, 634–638 (1950).
Hahn, P. F.: Artificial radioisotope therapy. New York: Academic Press 1951.
— Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
— Treatment of cancer and allied diseases. I. Principals of treatment, edit. G. T. Pack and I. M. Ariel. New York: Paul B. Hoeber 1958.
— The adjuvant therapy of bronchogenic carcinoma following pneumonectomy or lobectomy with the intrathroracic introduction of silver-coated radioactive colloidal gold. Stuttgart: F. K. Schattauer 1960.
—, and E. L. Carothers: Radioactive metallic gold colloids coated with silver and their distribution in lung and its lymphatics following intra-pulmonary administration; therapeutic implications in primary lung and bronchogenic tumors. Brit. J. Cancer 5, 400–404 (1951).
— —and H.Brummitt: Synergistic effect of internal irradiation and phlebotomy on production of cirrhosis and ascites in dogs. Amer. J. Physiol. 175, 162–166 (1953).
Hahn, P. F., E. L. Carothers, G. W. Hilliard, L. Bernard and M. A. Jackson: Therapeutic use of artificial radioisotopes. New York: John Wiley & Sons 1956.
— J. P. B. Goodell, C. W. Sheppard, R. O. Cannon and H. C. Francis: Direct infiltration of radioactive isotopes as means of delivering ionizing radiation to discrete tissues. J. Lab. clin. Med. 32, 1442—1453 (1947).
— D.G. Lareau, B. L. Feaster, E.L.Caro thers, F. Gollan, G. R. Meneely and D. Sherman : Intravenous radioactive gold in the treatment of chronic leukemia. Comparison of results with conventional roentgen therapy to the splenic area. Acta radiol. (Stockh.) 50, 565–572 (1958).
— G. R. Meneely and E. L. Carothers: The use of gold and silver-coated radioactive gold colloids in the palliation of ascites and pleural effusions. Brit. J. Radiol. 31, 240–245 (1958).
— E. B. Wells and G. R. Meneely : Circulating red cell mass in polycythemia vera as determined by red blood cells tagged with radioactive isotope of iron. Sth. med. J. (Bgham, Ala.) 43, 947–950 (1950).
—, and G.H.Whipple: Iron metabolism; its absorption, storage utilization in experimental anemia. Amer. J. med. Sci. 191, 24–42 (1936).
Hamilton, J. G., M. H. Soley and K. B. Eichhorn : Deposition of radioactive iodine in human thyroid tissue. Univ. Calif. Publ Pharmacol. 1, 339–367 (1940).
Hertz, S., and A. Roberts: Radioactive iodine as indicator in thyroid physiology; use of radioactive iodine in differential diagnosis of 2 types of Grave’s disease. J. clin. Invest. 21, 31–32 (1942).
Hursh, J. B., and J. W. Karr: Manual of artificial radioisotope therapy. New York: Academic Press 1951.
Jacobs, M.L. : Radioactive colloidal chromic phosphate to control pleural effusion and ascites. J. Amer. med. Ass. 166, 597–599 (1958).
Jaffe, H.L.: Treatment of malignant serous effusions with radioactive colloidal chromic phosphate. Amer. J. Roentgenol. 74, 657–666 (1955).
Keetel, W. C, and H. B. Elkins : Experience with radioactive colloidal gold in treatment of ovarian carcinoma. Amer. J. Obstet. 71, 553–568 (1956).
Kent, E. M., and C. J. Moses: Radioactive isotopes in palliative management of carcinomatosis of pleura. J. thorac. Surg. 22, 503–516 (1951).
Keston, A. S., R.-P. Ball, Z. K. Frantz and W. W. Palmer: Storage of radioactive iodine in metastasis from thyroid carcinoma. Science 95, 362–363 (1942).
Kottmeier, H. L., and G. Moberger: Experience with radioactive colloidal gold as additional treatment in radiotherapy of uterine cancer. Acta obstet, gynec. scand. 34, 1–29 (1955).
Lange, K. H., J. L. Shields and H. M. Rozen-DAAL : Colloidal radioactive chromic phosphate in control of malignant effusions. N.Y. St. J. Med. 56, 1928–1931 (1956).
Lawrence, J. H.: Polycythemia. New York: Grune & Stratton 1955.
— N.I.Berlin and E. L. Huff: Nature and treatment of polycythemia; studies on 263 patients. Medicine (Baltimore) 32, 323–388 (1953).
— K.G.Scott and J. W. Tuttle: Studies on leukemia with aid of radioactive phosphorus. New int. Clin. 3, 33–58 (1939).
Matuska, E. A., P. F. Hahn, E. I. Carlson, S. H. Auerbach and G. E. Meneely: Lymphatic drainage of silvercoated radioactive gold colloid following intrathoracic administration to pneumonectomized dogs. J. thorac. Surg. 30, 525–530 (1955).
————— Further observations on the
Meneely, G. E., S. H. Auerbach, C. C. Woodcock, E. C. KoRY and P. F. Hahn: Transbronchial instillation of radioactive gold colloid in the lung of the dog. Distribution studies, survival and pathology. Amer. J. med. Sci. 225, 172 (1953).
Moore, E.V., D.Gamble and E.L. Libby: Experiences with radioactive chromic phosphate in urologicai tumors. A.M.A. Arch. Surg. 72, 464–468 (1956).
Müller, J. H. : Über die Verwendung von künstlichen radioaktiven Isotopen zur Erzielung von lokalisierten biologischen Strahlenwirkungen. Experientia (Basel) 1, 199–200 (1945).
— Über die multiplen Anwendungsmöglichkeiten eines langlebigen künstlichen radioaktiven Isotops (Co-60) in flüssiger Form für die Strahlentherapie maligner Tumoren. Schweiz. med. Wschr. 79, 547–551 (1949).
— Therapeutic use of artificial radioisotopes, edit. P.F. Hahn. New York: John Wiley & Sons 1956.
Myant, N.B.: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Nylander, P. E. A., E. Laustela, T. M. Scheinin and M. Turunen : Observations on the use of radioactive gold (Au 198) in the treatment of malignant tumours of the lungs and pleura. Ann. Med. exp. Fenn. 34, 352–361 (1956).
Osgood, E.E.: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Pochin, E.E.: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
— N. B. Myant and B. D. Corbett: Leukaemia following radioiodine treatment of hyperthyroidism. Brit. J. Radiol. 29, 31–35 (1956).
Quimby, E.B.: Artificial radioisotope therapy, edit. P. F. Hahn. New York: Academic Press 1951.
Quimby, E.H., S. Feitelberg and S. Silver: Radioactive isotopes in clinical practice. Philadelphia: Lea and Febiger 1958.
Rawson, R. W., L. D. Marinelli, B. N. Skanse, J. B. Trunnell and R. G. Fluharty: Effect of total thyroidectomy on function of metastatic thyroid cancer. J. clin. Endocr. 8, 826–841 (1948).
—, and J. B. Trunnell: Artificial radioisotope therapy, edit. P. F. Hahn. New York: Academic Press 1951.
Rusche, C, and H.L. Jaffe: Palliative treatment of prostatic cancer with radioactive colloidal chromic phosphate; 3 years experience and results. J. Urol. (Baltimore) 74, 393–401 (1955).
Seidlin, S. M., L. D. Marinelli and E. Oshry: Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of thyroid. J. Amer. med. Ass. 132, 838–847 (1946).
Shelley, H., and P.F.Hahn: Unpublished data.
Sherman, A. I.: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Simon, N.: Radioactive gold treatment; results in 85 effusions due to cancer. J. Mt Sinai Hosp. 22, 96–98 (1955).
Smithers, D. W., D. M. Wallace and N. G. Trott: Therapeutic use of artificial radioisotopes, edit. P. F. Hahn. New York: John Wiley & Sons 1956.
Stroebel, C.S., and B.E.Hall: Artificial radioisotope therapy, edit. P. F. Hahn. New York: Academic Press 1951.
Walton, R. J., and W. K. Sinclair: Intracavitary irradiation with radioactive colloidal gold in palliative treatment of malignant pleural and peritoneal effusions. Brit. med. Bull. 8, 165–172 (1952).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hahn, P.F. (1971). Irradiation with open (incorporated) radio-isotopes. In: Vieten, H., Wachsmann, F. (eds) Allgemeine Strahlentherapeutische Methodik / Methods and Procedures of Radiation Therapy. Handbuch der Medizinischen Radiologie / Encyclopedia of Medical Radiology, vol 16 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80605-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-80605-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80606-3
Online ISBN: 978-3-642-80605-6
eBook Packages: Springer Book Archive